[1] Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China, Volume I(中华人民共和国药典一部)[M]. Beijing: China Medical Science Press, 2010: 183-184.
[2] LIN L, NI B, LIN H, et al.Traditional usages, botany, phytochemistry, pharmacology and toxicology of Polygonum multiflorum Thunb.: a review[J]. Journal of Ethnopharmacology, 2014, 159(3): 158-183.
[3] WANG Q, WEN HR, YAN JB, et al.Study on the components of Polygonum multiflorum aqueous extract in rats after long-term administration[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2022, 19(6): 620.
[4] RAO T, LIU Y, ZENG X, et al. The hepatotoxicity of Polygonum multiflorum: the emerging role of the immune-mediated liver injury[J]. Acta Pharmacologica Sinica, 2021, 42(1): 27-35.
[5] HU X, DU T, DAI S, et al. Identification of intrinsic hepatotoxic compounds in Polygonum multiflorum Thunb. using machine-learning methods[J]. Journal of Ethnopharmacology, 2022, 298(1): 115620.
[6] SONG L, WANG Q, BI YN, et al. Study on liver and kidney toxicity of 4 components of Polygoni Multifori Radix on mice after intragastric administration for 14 days[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2018, 15(9): 513-517.
[7] VALDÉS A, LUCIO-CAZAÑA F J, CASTRO-PUYANA M, et al. Comprehensive metabolomic study of the response of HK-2 cells to hyperglycemic hypoxic diabetic-like milieu[J]. Scientific Reports, 2021, 11(1): 1-14.
[8] LI Y, OO ZY, CHANG SY, et al.An in vitro method for the prediction of renal proximal tubular toxicity in humans[J]. Toxicology Research, 2013, 2(5): 352-365.
[9] QIU X, ZHOU X, MIAO Y, et al.An in vitro method for nephrotoxicity evaluation using HK-2 human kidney epithelial cells combined with biomarkers of nephrotoxicity[J]. Toxicology Research, 2018, 7(6): 1205-1213.
[10] WANG CF, CHEN M, WU XD, et al.Participation of cathepsin B in emodin-induced apoptosis in HK-2 cells[J]. Journal of Southeast University (Medical Science Edition)(东南大学学报医学版), 2008, 27(6): 404-408.
[11] ZHU S, JIN J, WANG Y, et al.The endoplasmic reticulum stress response is involved in apoptosis induced by aloe-emodin in HK-2 cells[J]. Food and Chemical Toxicology, 2012, 50(3-4): 1149-1158.
[12] IX JH, SHLIPAK MG.The promise of tubule biomarkers in kidney disease: a review[J]. American Journal of Kidney Diseases, 2021, 78(5): 719-727.
[13] MOSSOBA ME, VOHRA SN, WIESENFELD PL, et al.Nephrotoxicity of combining 2-phenethylamine and N, N-dimethyl-β-phenethylamine[J]. Applied In Vitro Toxicology, 2016, 2(1): 49-55.
[14] MAO KF, LUO JL, LIN FW, et al.Effect and mechanism of terminal fucosylation inhibitor on ciclosporin-induced renal epithelial-mesenchymal transition[J]. Organ Transplantation(器官移植), 2022,13(5): 626-633.
[15] WANG C, WU X, CHEN M, et al.Emodin induces apoptosis through caspase 3-dependent pathway in HK-2 cells[J]. Toxicology, 2007, 231(2-3): 120-128.
[16] TEKA T, WANG L, GAO J, et al.Polygonum multiflorum: recent updates on newly isolated compounds, potential hepatotoxic compounds and their mechanisms[J]. Journal of Ethnopharmacology, 2021, 271: 113864.
[17] GUNNESS P, ALEKSA K, KOSUGE K, et al.Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity[J]. Canadian Journal of Physiology and Pharmacology, 2010, 88(4): 448-455.
[18] DA HY, JIANG ZZ, WANG CF, et al.Study on toxic effects of rhein and emodin on human renal tubular epithelial cellsin vitro[J]. Chinese Traditional and Herbal Drugs(中草药), 2009, 40(1): 102-105.
[19] BAE E, KIM JH, JUNG MH, et al.Paricalcitol attenuates contrast-induced acute kidney injury by regulating mitophagy and senescence[J]. Oxidative Medicine and Cellular Longevity, 2020, 2020(3): 1-13.
[20] FENG J, CHEN Z, LIANG W, et al.Roles of mitochondrial DNA damage in kidney diseases: a new biomarker[J]. International Journal of Molecular Sciences, 2022, 23(23): 15166.
[21] ZAIB S, HAYYAT A, ALI N, et al.Role of mitochondrial membrane potential and lactate dehydrogenase a in apoptosis[J]. Anti-cancer Agents in Medicinal Chemistry, 2022, 22(11): 2048-2062.
[22] DONG X, FU J, YIN X, et al.Emodin: a review of its pharmacology, toxicity and pharmacokinetics[J]. Phytotherapy Research, 2016, 30(8): 1207-1218.
[23] DONG X, ZENG Y, LIU Y, et al.Aloe‐emodin: a review of its pharmacology, toxicity, and pharmacokinetics[J]. Phytotherapy Research, 2020, 34(2): 270-281. |